Amylin Pharmaceuticals, Inc.
| Article | Date | Source |
|---|
| Amylin's three-party good-bye | -- | Nature Biotechnology |
| Amylin's $7 billion GLP-1 deal | -- | Nature Biotechnology |
| Amylin Sues Eli Lilly for Alleged Anticompetitive Activity | -- | News - BioPharm |
| Amylin's diabetes shock | -- | Nature Biotechnology |
| Amylin's $1 billion heavyweight deal | -- | Nature Biotechnology |
| Amylin Launches This Week I Will Pledge Campaign to Encourage Adults with Type 2 Diabetes to Set Weekly Goals While Giving Back to Diabetes Community | September 27, 2012 | Pharma News - Business Wire |
| Bristol-Myers Squibb Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, Inc. | August 01, 2012 | Pharma News - Business Wire |
| Bristol-Myers Squibb starts Amylin tender offer | July 10, 2012 | Health News - CNBC |
| Bristol-Myers Squibb Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc. | July 10, 2012 | Pharma News - Business Wire |
| BMS to Acquire Amylin for $5.3 Billion Plus Debt | July 06, 2012 | Burrill Report |
| Amylin Pharmaceuticals, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Bristol-Myers Squibb Company | July 02, 2012 | Pharma News - PR Newswire |
| AstraZeneca PLC, Bristol-Myers Squibb Company Join Forces in $7 Billion Deal for Amylin Pharmaceuticals, Inc. | July 02, 2012 | BioSpace |
| Bristol-Myers, AZ aim for diabetes glory with Amylin buy | July 02, 2012 | FiercePharma |
| Ahead of the Bell: Amylin Pharma shares climb | July 02, 2012 | Health News - CNBC |
| Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amylin Pharmaceuticals, Inc. | July 02, 2012 | Pharma News - PR Newswire |
| Bristol-Myers outbids Big Pharma pack and nabs Amylin for $5.3B | July 01, 2012 | FierceBiotech |
| Bristol-Myers Squibb to Buy Amylin for $7 Billion | June 30, 2012 | New York Times- Pharmaceuticals |
| Bristol-Myers Buys Amylin for $5.3B, Getting Diabetes Drugs | June 30, 2012 | Xconomy Life Sciences |
| Bristol-Myers Squibb and AstraZeneca Expand Diabetes Alliance Through Bristol-Myers Squibb’s Acquisition of Amylin Pharmaceuticals | June 30, 2012 | Pharma News - Business Wire |
| Amylin shareholder sues board for self-enrichment | June 27, 2012 | FiercePharma |
| Novartis, four others weigh Amylin final bids: sources | June 26, 2012 | Health News - CNBC |
| FDA review cites Amylin for withholding data on Bydureon app | June 26, 2012 | FierceBiotech |
| FDA: Amylin Pharmaceuticals, Inc. Concealed Heart Safety Risks of Key Diabetes Drug | June 25, 2012 | BioSpace |
| Sanofi, Novo Nordisk, Amylin all tout diabetes treatments at ADA | June 11, 2012 | FiercePharma |
| Novo Nordisk A/S Says Victoza Superior to Amylin Pharmaceuticals, Inc. Rival | June 11, 2012 | BioSpace - Breaking News |
| Novo Nordisk says Victoza superior to Amylin rival | June 11, 2012 | Health News - CNBC |
| FDA Seeks Data on Delivery Method for Amylin Pharmaceuticals, Inc. Drug | June 06, 2012 | BioSpace |
| Amylin Pharmaceuticals, Inc. Preps for 2nd Round After Bids Boost Appeal | June 06, 2012 | BioSpace |
| FDA seeks data on delivery method for Amylin drug | June 05, 2012 | Health News - CNBC |
| Amylin Pharmaceuticals, Inc. Said to Attract Interest From Pfizer Inc., AstraZeneca PLC, Sanofi (France) | May 15, 2012 | BioSpace |
| Big-name pharmas peer at Amylin's books to prep for bids | May 15, 2012 | FiercePharma |
| Buzz: Big Pharma suitors line up for a look at Amylin's books | May 15, 2012 | FierceBiotech |
| <b>Icahn</b> and Amylin Pharmaceuticals, Inc. Have May 10 Hearing for Proxy War | April 25, 2012 | BioSpace - Breaking News |
| Amylin Pharmaceuticals has several potential buyers | April 23, 2012 | Health News - BizJournals.com |
| Amylin Pharma rises on report of new sale talks | April 23, 2012 | Health News - CNBC |
| Is Merck interested in buying Amylin Pharmaceuticals? | April 23, 2012 | Health News - BizJournals.com |
| Amylin's up for bid. Who'll step in line? | April 23, 2012 | FiercePharma |
| Amylin Explores Sale, Hires Bankers: Sources | April 23, 2012 | Health News - CNBC |
| Buzz: Amylin brings in the bankers to spur an auction | April 23, 2012 | FierceBiotech |
| The Amylin Pharmaceuticals, Inc. Puzzle and Tracking Bydureon Sales | April 16, 2012 | BioSpace - Breaking News |
| Predictably, Icahn sues Amylin to open proxy fight | April 10, 2012 | FiercePharma |
| <b>Icahn</b> Sues Amylin Pharmaceuticals, Inc. in Shake-up Try | April 10, 2012 | BioSpace |
| Icahn sues Amylin in hopes a proxy fight will trigger sale | April 10, 2012 | FierceBiotech |
| Amylin Pharmaceuticals, Inc. Completes Biologics License Application for Metreleptin to Treat Diabetes and/or Hypertriglyceridemia in Patients With Rare Forms of Lipodystrophy | April 03, 2012 | BioSpace - Breaking News |
| Amylin Completes Biologics License Application for Metreleptin to Treat Diabetes and/or Hypertriglyceridemia in Patients With Rare Forms of Lipodystrophy | April 03, 2012 | Pharma News - PR Newswire |
| Amylin Pharmaceuticals, Inc. and Illumina, Inc. Benefit From JOBS Act | March 30, 2012 | Inside Industry - Gen |
| Amylin Reportedly Rejected Bristol-Myers Squibb's $3.5B Takeover Offer | March 29, 2012 | Inside Industry - Gen |
| Is an Amylin takeover inevitable after the BMS rejection? | March 29, 2012 | FierceBiotech |
| Amylin Booms on Report it Rejected Bristol’s $3.5B Takeover Bid | March 28, 2012 | Xconomy Life Sciences |
| Amylin reportedly stiff-armed $3.5B offer from BMS | March 28, 2012 | FiercePharma |
| Amylin jumps on word of offer from Bristol-Myers | March 28, 2012 | Health News - CNBC |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company Receive EU OK for New Byetta Use | March 23, 2012 | BioSpace |
| Amylin Pharmaceuticals Announces Pricing of Public Offering of Common Stock | March 08, 2012 | Pharma News - PR Newswire |
| Amylin Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference | March 08, 2012 | Biotech News - PR Newswire |
| Amylin Pharmaceuticals Announces Public Offering of Common Stock | March 07, 2012 | Medical Pharma - PR Newswire |
| Amylin Supports Rare Disease Day 2012 | February 29, 2012 | Medical Pharma - PR Newswire |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company Say Recommends Approval of BYETTA for Use With Basal Insulin | February 21, 2012 | BioSpace - Breaking News |
| Amylin takes 4Q loss as Lilly partnership ends | February 07, 2012 | Health News - CNBC |
| Amylin's OH plant prepped for Bydureon's U.S. debut | February 01, 2012 | FiercePharma Manufacturing |
| Amylin Pharmaceuticals to Webcast 2011 Year-End Financial Results | January 30, 2012 | Biotech News - PR Newswire |
| Movers roundup: Amylin Pharma, St. Joe | January 30, 2012 | Health News - CNBC |
| Amylin jumps after FDA clears diabetes drug | January 30, 2012 | Health News - CNBC |
| FDA Approves Amylin Pharmaceuticals, Inc. and Alkermes plc's BYDUREON??? -- The First and Only Once-Weekly Treatment for Type 2 Diabetes | January 30, 2012 | BioSpace |
| Amylin's Once-Weekly Diabetes Injection Finally Wins FDA Approval | January 29, 2012 | Pharmaceutical - Moreover |
| UPDATED: FDA (finally) stamps an approval on Amylin's Bydureon | January 27, 2012 | FierceBiotech |
| Amylin Outlines Corporate Strategy to Maximize Global Value of Diabetes Franchise and Advance Key Pipeline Candidates | January 09, 2012 | Pharma News - PR Newswire |
| Amylin Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference | January 03, 2012 | Biotech News - PR Newswire |
| Amylin Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Healthcare Conference | November 23, 2011 | Medical Pharma - PR Newswire |
| Analyst sees positives for Amylin in Lilly split | November 14, 2011 | Health News - CNBC |
| Amylin and Lilly Part Ways on Byetta | November 11, 2011 | Burrill Report |
| Amylin Pharmaceuticals Announces Date and Time Change to Previously Announced Presentation at the Credit Suisse 2011 Healthcare Conference | November 09, 2011 | Pharma News - PR Newswire |
| Amylin CEO on Exenatide | November 08, 2011 | Health News - CNBC |
| Summary Box: Lilly, Amylin end collaboration | November 08, 2011 | Health News - CNBC |
| Amylin gets Byetta custody in split with Lilly | November 08, 2011 | FiercePharma |
| Amylin and Eli Lilly Part Ways on Diabetes Drug; Alkermes Deal Intact | November 08, 2011 | Xconomy Life Sciences |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company End Bydureon Pact; to Make $1.45 Billion in Payments | November 08, 2011 | BioSpace |
| Lilly, Amylin End Diabetes Alliance | November 08, 2011 | Contract Pharma |
| Amylin to Pay Lilly $250M to End Exenatide Partnership and Litigation | November 08, 2011 | Inside Industry - Gen |
| Eli Lilly, Amylin end collaboration, litigation | November 08, 2011 | Health News - CNBC |
| Blockbuster breakup: Amylin buys out Lilly's exenatide rights in $1.6B deal | November 08, 2011 | FierceBiotech |
| Lilly and Amylin Mutually Agree to End Diabetes Alliance and Transition Exenatide Responsibility to Amylin | November 08, 2011 | Pharma News - PR Newswire |
| Amylin Pharmaceuticals to Present at the Credit Suisse 2011 Healthcare Conference | November 02, 2011 | Biotech News - PR Newswire |
| Optimism on Diabetes Medication Grows -- MannKind and Amylin Benefit / The Paragon Report Provides Equity Research on MannKind & Amylin Pharmaceuticals | November 02, 2011 | Biotechnology - Moreover |
| Optimism on Diabetes Medication Grows -- MannKind and Amylin Benefit | November 02, 2011 | Biotechnology - Moreover |
| Eli Lilly and Company, Amylin Pharmaceuticals, Inc. Diabetes Drug Wins Approval for Expanded Use | October 20, 2011 | BioSpace |
| Eli Lilly and Company, Amylin Pharmaceuticals, Inc. Diabetes Drug Wins Approval for Expanded Use; Stock Rises +1.24 (12.11%) @ 1:37PM EDT | October 20, 2011 | BioSpace |
| Amylin Pharmaceuticals is Up After Good Earnings | October 20, 2011 | Pharmaceutical - Moreover |
| Eli Lilly and Company & Amylin Pharmaceuticals, Inc. Diabetes Drug Wins Approval for Expanded Use | October 20, 2011 | BioSpace |
| Eli Lilly and Company-Amylin Pharmaceuticals, Inc.'s Diabetes Drug Wins Approval for Expanded Use | October 20, 2011 | BioSpace |
| Amylin Pharmaceuticals, Inc. Reports Third Quarter Financial Results | October 20, 2011 | BioSpace - Breaking News |
| Lilly, Amylin win NICE nod for Bydureon | October 18, 2011 | FiercePharma |
| Amylin Pharmaceuticals, Inc. to Webcast Third Quarter Results | October 13, 2011 | BioSpace - Breaking News |
| Amylin's diabetes drug gets positive results | September 13, 2011 | Health News - BizJournals.com |
| Amylin Pharmaceuticals, Inc. (AMLN) Release: Analyses Find Type 2 Diabetes Patients Treated with BYDUREON(TM) Experienced Reduction in Cardiovascular Risk Factors: Results Presented at EASD 20 | September 13, 2011 | Biotechnology - Moreover |
| Lilly, Amylin release new analysis of Bydureon | September 12, 2011 | Health News - CNBC |
| Amylin Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference | September 07, 2011 | Biotech News - PR Newswire |
| FDA Sets Review Deadline For Amylin Pharmaceuticals, Inc. Diabetes Drug | August 11, 2011 | BioSpace |
| FDA sets review for Amylin diabetes drug | August 10, 2011 | Health News - CNBC |
| Amylin and Takeda drop combo obesity drug development | August 08, 2011 | Pharmaceutical - Moreover |
| Amylin and Takeda discontinue development of pramlintide/metreleptin combination treatment | August 05, 2011 | Pharmaceutical - Moreover |
| Amylin and Takeda discontinue obesity drug | August 05, 2011 | Pharmaceutical - Moreover |
| Amylin Pharmaceuticals, Inc., Takeda Pharmaceutical Co. Ltd. Halt Obesity Drug Development Following Commercial Reassessment of the Program | August 05, 2011 | BioSpace |
| Takeda, Amylin pull plug on obesity trial | August 05, 2011 | FierceBiotech |
| Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program Collaboration Will Explore Potential of Other Assets to Address Obesity Epidemic | August 05, 2011 | Pharmaceutical - Moreover |
| Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Company Limited Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of Program | August 05, 2011 | Pharmaceutical - Moreover |
| Amylin & Takeda Halt Obesity Drug Development | August 05, 2011 | Xconomy Life Sciences |
| Amylin and Takeda Discontinue Development of Pramlintide/Metreleptin Combination Treatment for Obesity Following Commercial Reassessment of the Program | August 04, 2011 | Pharma News - PR Newswire |
| Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News | August 04, 2011 | Xconomy Life Sciences |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes's BYDUREON Reply Submitted to FDA
| July 28, 2011 | BioSpace |
| Amylin heading back to the FDA with Bydureon app | July 27, 2011 | FierceBiotech |
| Amylin losses narrow but miss analysts predictions | July 26, 2011 | Biotechnology - Moreover |
| Amylin Pharma narrows 2Q loss as expenses fall | July 26, 2011 | Health News - CNBC |
| Amylin Pharmaceuticals hires GM for West Chester facility | July 20, 2011 | Health News - BizJournals.com |
| Amylin Pharmaceuticals, Inc. to Webcast Second Quarter Results | July 20, 2011 | BioSpace - Breaking News |
| Amylin trades higher on diabetes drug promise | July 08, 2011 | Health News - CNBC |
| UPDATED: Amylin shares jump on upbeat heart rate study with diabetes drug | July 08, 2011 | FierceBiotech |
| Biotech Stocks: Amylin and Alkermes shine in drug-stocks trading | July 08, 2011 | Pharmaceutical - Moreover |
| Amylin and Alkermes shine in drug-stocks trading | July 08, 2011 | Biotechnology - Moreover |
| Amylin Pharmaceuticals, Inc., Alkermes Shares Jump on Success in Bydureon Study | July 08, 2011 | BioSpace |
| Amylin shares jump on upbeat heart rate study with diabetes drug | July 08, 2011 | FierceBiotech |
| MannKind and Amylin Embrace the Future of Diabetes Treatment | July 07, 2011 | Marketwire - Pharma and Biotech |
| Amylin Buoyed by Diabetes Trials, Vital Therapies Raises $22.6M, Acutus Medical Gets Seed Cash, & More San Diego Life Sciences News | June 30, 2011 | Xconomy Life Sciences |
| Eli Lilly and Company, Alkermes and Amylin Pharmaceuticals, Inc. Announces BYDUREON(TM) Receives Marketing Authorization in Europe | June 21, 2011 | BioSpace - Breaking News |
| Amylin Pharmaceuticals to Present Promising New Data on the Company's Diabetes Programs at ADA 2011 | June 20, 2011 | Biotech News - PR Newswire |
| Court denies Amylin request in Lilly dispute | June 08, 2011 | Health News - CNBC |
| Court denies injunction on Lilly in Amylin case | June 08, 2011 | Health News - CNBC |
| U.S. District Court Rules in Favor of Lilly in Amylin Litigation | June 08, 2011 | Pharma News - PR Newswire |
| Amylin Pharmaceuticals Issues Statement Regarding U.S. District Court Order | June 08, 2011 | Pharma News - PR Newswire |
| Amylin says drug helped metabolic disease symptoms | June 06, 2011 | Health News - CNBC |
| FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News | June 02, 2011 | Xconomy Life Sciences |
| Amylin Pharmaceuticals, Inc. to Present at Goldman, Sachs & Co. 32nd Annual Global Healthcare Conference and Jefferies and Co. Global Life Sciences Conference | June 01, 2011 | BioSpace - Breaking News |
| Amylin Pharmaceuticals to Present at Goldman Sachs 32nd Annual Global Healthcare Conference and Jefferies Global Life Sciences Conference | May 31, 2011 | Biotech News - PR Newswire |
| Amylin wins TRO in fight over Lilly marketing pact | May 26, 2011 | FiercePharma |
| Amylin Pharmaceuticals, Inc. Obtains Temporary Restraining Order Against Eli Lilly and Company | May 26, 2011 | BioSpace |
| Amylin Obtains Temporary Restraining Order Against Eli Lilly | May 26, 2011 | Inside Industry - Gen |
| Eli Lilly and Company Comments on Court Ruling in Amylin Pharmaceuticals, Inc. Litigation | May 26, 2011 | BioSpace - Breaking News |
| Amylin Pharmaceuticals Obtains Temporary Restraining Order Against Eli Lilly | May 26, 2011 | Biotech News - PR Newswire |
| Lilly Comments on Court Ruling in Amylin Litigation | May 26, 2011 | Pharma News - PR Newswire |
| Amylin Sues Lilly Over Boehringer Deal | May 20, 2011 | Burrill Report |
| Shire Pays $750M for Advanced BioHealing, Amylin Sues Lilly, Pacira CEO Describes His Most Difficult Task, & More San Diego Life Sciences News | May 19, 2011 | Xconomy Life Sciences |
| Amylin Pharmaceuticals to Present at Annual Meeting of Stockholders | May 17, 2011 | Pharma News - PR Newswire |
| Lilly Provides Its Perspective in Response to Amylin Lawsuit | May 16, 2011 | Pharma News - PR Newswire |
| Summary Box: Amylin sues partner Eli Lilly and Co. | May 16, 2011 | Health News - CNBC |
| Amylin Pharmaceuticals, Inc. Sues Eli Lilly and Company, Arguing Breach of Contract in Marketing Rival Diabetes Drug | May 16, 2011 | BioSpace |
| Amylin Sues Eli Lilly, Arguing Breach of Contract in Marketing Rival Diabetes Drug | May 16, 2011 | Xconomy Life Sciences |
| Amylin waging legal war with Lilly over blockbuster Boehringer pact | May 16, 2011 | FierceBiotech |
| Lilly Provides Statement in Response to Amylin Lawsuit | May 16, 2011 | Medical Pharma - PR Newswire |
| Amylin sues Eli Lilly over drug development deal | May 16, 2011 | Health News - CNBC |
| Amylin Pharmaceuticals Files Suit Against Eli Lilly | May 16, 2011 | Pharma News - PR Newswire |
| Live Webinar: Amylin's Improved Aseptic Gowning and Monitoring Program Using MODA? Solution | May 13, 2011 | Pharmaceutical - Moreover |
| JDRF and Amylin Partner to Investigate Co-Formulating Two Hormones for Treatment of Type 1 Diabetes | May 10, 2011 | Pharma News - PR Newswire |
| Amylin Pharmaceuticals, Inc. (AMLN) to Present at the Bank of America (BAC) | May 07, 2011 | Biotechnology - Moreover |
| Amylin Pharmaceuticals to Present at the Bank of America 2011 Healthcare Conference | May 05, 2011 | Pharma News - PR Newswire |
| Amylin Pharmaceuticals to Present at the Deutsche Bank 36th Annual Healthcare Conference | April 27, 2011 | Biotech News - PR Newswire |
| West Wireless Repositions Itself as an Impartial Arbiter, Amylin Makes Headway in Europe, VCs Debate Viability of Venture-Backed Biotech, & More San Diego Life Sciences News | April 21, 2011 | Xconomy Life Sciences |
| Financial Report: Amylin 1Q11 | April 18, 2011 | Contract Pharma |
| Merck gains, Amylin rallies in early trading | April 15, 2011 | Biotechnology - Moreover |
| Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy | April 15, 2011 | Pharma News - PR Newswire |
| Lilly, Amylin win EU recommendation for Bydureon | April 15, 2011 | FierceBiotech |
| Amylin & Takeda suspended the study of pramlintide/metreleptin for obesity | March 25, 2011 | Pharmaceutical - Moreover |
| Amylin & Takeda suspend obesity trial | March 18, 2011 | Pharmaceutical - Moreover |
| Amylin and Takeda Suspend Obesity Drug Trial | March 18, 2011 | Pharmaceutical - Moreover |
| Amylin Suspends Obesity Drug Development, Sapphire Energy Partners with Monsanto, 23andMe Gets Connected to UCSD’s Fowler, & More San Diego Life Sciences News | March 17, 2011 | Xconomy Life Sciences |
| Amylin's Diet Drug Crumbles | March 16, 2011 | Pharmaceutical - Moreover |
| Amylin and Takeda Suspend Obesity Study to Consider Metreleptin Data | March 16, 2011 | Xconomy Life Sciences |
| Amylin and Takeda Halt Phase II Obesity Trial | March 16, 2011 | Inside Industry - Gen |
| Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Co. Ltd. Voluntarily Suspend Clinical Activities in Obesity Trial | March 16, 2011 | BioSpace |
| Amylin and Takeda Voluntarily Suspend Clinical Activities in Obesity Trial | March 16, 2011 | Biotech News - PR Newswire |
| Lilly, Amylin say diabetes drug trial fares well | March 10, 2011 | Health News - CNBC |
| Amylin Pharmaceuticals, Inc. Exenatide Once Monthly Showed Positive Results in Phase 2 Study | March 10, 2011 | BioSpace |
| Amylin Pharmaceuticals, Inc. (AMLN) to Present at the Barclays Capital | March 10, 2011 | Biotechnology - Moreover |
| Amylin Pharmaceuticals to Present at the Barclays Capital 2011 Global Healthcare Conference | March 09, 2011 | Biotech News - PR Newswire |
| Eli Lilly and Company, Amylin Pharmaceuticals, Inc. and Alkermes' Bydureon Fails Against Novo Nordisk A/S's Victoza in Head to Head Study | March 03, 2011 | BioSpace |
| Eli Lilly and Company, Amylin Pharmaceuticals, Inc. and Alkermes' Bydureon Fails Against Novo Nordisk A/S's Victoza in Head to Head Study; Stock Falls 24.05% @ 1:09PM EST | March 03, 2011 | BioSpace |
| Eli Lilly and Company, Amylin Pharmaceuticals, Inc. and Alkermes' Bydureon Fails Against Novo Nordisk A/S's Victoza in Head to Head Study; Stock Falls 24.98% @10:18AM EST. | March 03, 2011 | BioSpace |
| Amylin Pharmaceuticals, Inc. (AMLN) to Present at the | February 09, 2011 | Biotechnology - Moreover |
| Amylin Pharmaceuticals, Inc. 4th-Quarter Loss Narrows, Byetta Sales Drop | January 27, 2011 | BioSpace |
| Amylin takes smaller 4Q loss as expenses decline | January 27, 2011 | Health News - CNBC |
| Amylin Pharmaceuticals Reports 2010 Financial Results | January 26, 2011 | Pharma News - PR Newswire |
| Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug | January 21, 2011 | Xconomy Life Sciences |
| Amylin Pharmaceuticals to Webcast Year-End Financial Results | January 19, 2011 | Pharma News - PR Newswire |
| Amylin to Advance Key Value-Driving Opportunities in 2011 | January 10, 2011 | Biotech News - PR Newswire |
| Amylin Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference | January 03, 2011 | Pharma News - PR Newswire |
| Amylin Pharmaceuticals, Inc. and Eli Lilly and Company Seek Expanded Use of BYETTA(R) Along with Basal Insulin | December 27, 2010 | BioSpace - Breaking News |
| Amylin and Lilly seek expanded Byetta approval | December 22, 2010 | Health News - CNBC |
| Amylin and Lilly Seek Expanded Use of BYETTA® Along with Basal Insulin | December 22, 2010 | Medical Pharma - PR Newswire |
| Amylin Pharmaceuticals, Inc. Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy | December 20, 2010 | BioSpace - Breaking News |
| Amylin Submits Clinical and Nonclinical Sections of Rolling Biologics License Application for Metreleptin to Treat Rare Forms of Lipodystrophy | December 20, 2010 | Biotech News - PR Newswire |
| AMYLIN PHARMACEUTICALS HAS THE BEST RELATIVE PERFORMANCE IN THE BIOTECHNOLOGY ... | December 14, 2010 | Biotechnology - Moreover |
| Juvenile Diabetes Research Foundation and Amylin Pharmaceuticals Partner to Investigate Metreleptin as Potential Therapy to Improve Blood Glucose Control in Type 1 Diabetes | November 16, 2010 | Medical Pharma - PR Newswire |
| Amylin Pharmaceuticals to Present at the Citi 7th Annual US Small/Mid Cap Conference | November 09, 2010 | Biotech News - PR Newswire |
| Amylin posts bigger 3Q loss as Byetta sales slip | November 05, 2010 | Health News - CNBC |
| Amylin Pharmaceuticals Reports Third Quarter Financial Results | November 04, 2010 | Pharma News - PR Newswire |
| Amylin Pharmaceuticals to Present at the 2010 Credit Suisse Healthcare Conference | November 04, 2010 | Biotech News - PR Newswire |
| Amylin shares pop on analyst upgrade | October 27, 2010 | Health News - CNBC |
| Drug indexes split; Amylin jumps on upgrade | October 27, 2010 | Biotechnology - Moreover |
| Amylin Diabetes drug disappoints | October 22, 2010 | Burrill Report |
| Eli Lilly and Company (LLY)'s Diabetes Setbacks May Spur Shopping Spree Beyond Amylin Pharmaceuticals, Inc. (AMLN) | October 22, 2010 | Biotechnology - Moreover |
| Eli Lilly and Company's Diabetes Setbacks May Spur Shopping Spree Beyond Amylin Pharmaceuticals, Inc. | October 22, 2010 | BioSpace - Breaking News |
| Lilly's setbacks could lead to Amylin buyout, other deals | October 22, 2010 | FierceBiotech |
| Amylin Regroups From FDA Smackdown, CalciMedica Plans Trial of New Anti-Immune Drug, FDA Gives CareFusion Recall Highest Priority, & More San Diego Life Science News | October 21, 2010 | Xconomy Life Sciences |
| Wells Fargo, Delta, Amylin big market movers | October 20, 2010 | Health News - CNBC |
| Movers roundup: UnitedHealth, Amylin Pharma | October 20, 2010 | Health News - CNBC |
| Amylin shares dive on FDA's Bydureon rejection | October 20, 2010 | Health News - CNBC |
| FDA Seeks More Data On Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes Diabetes Drug | October 20, 2010 | BioSpace |
| FDA Seeks More Data On Amylin Pharmaceuticals, Inc., Eli Lilly and Company Diabetes Drug | October 20, 2010 | BioSpace |
| Amylin shares crater after FDA rejects Bydureon app | October 20, 2010 | FierceBiotech |
| Amylin says FDA wants more testing on Bydureon | October 20, 2010 | Health News - CNBC |
| Amylin Pharmaceuticals Announces Third Quarter Product Revenues; Quarterly Update Conference Call Canceled | October 19, 2010 | Biotech News - PR Newswire |
| FDA Approval Of Amylin Pharmaceuticals, Inc., Eli Lilly and Company, and Alkermes's Bydureon Diabetes Medicine Expected but Still Uncertain | October 18, 2010 | BioSpace |
| San Diego Biotech Industry, Amylin Pharmaceuticals, Inc., Turns Profitable | October 14, 2010 | BioSpace |
| Amylin Pharmaceuticals to Webcast Third Quarter Results | October 13, 2010 | Biotech News - PR Newswire |
| Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare and Baird Global Healthcare Conferences | September 07, 2010 | Biotech News - PR Newswire |
| After Yesterday's Rally of 2.73%, Amylin Pharmaceuticals Shares Could Pullback (AMLN) | August 30, 2010 | Biotechnology - Moreover |
| Analyst Research on Dendreon and Amylin Pharmaceuticals - Biotech Stocks Looking Averagely Attractiv | August 23, 2010 | Biotechnology - Moreover |
| Analyst Research on Dendreon and Amylin Pharmaceuticals - Biotech Stocks Looking Averagely Attractive | August 19, 2010 | Marketwire - Pharma and Biotech |
| Amylin Pharmaceuticals to Present at the Wedbush Life Sciences Conference 2010 | July 27, 2010 | Medical Pharma - PR Newswire |
| Amylin 2Q loss narrows on lower expenses | July 21, 2010 | Health News - CNBC |
| Amylin Pharmaceuticals Reports Second Quarter Financial Results | July 21, 2010 | Biotech News - PR Newswire |
| Amylin Pharmaceuticals to Webcast Second Quarter Results | July 14, 2010 | Pharma News - PR Newswire |
| Amylin's New Diabetes Drug Well Tolerated By Sufferers | June 28, 2010 | Health News - CNBC |
| <b>Hapoalim Securities</b> Expects Eli Lilly and Company To Acquire Amylin Pharmaceuticals, Inc. Post Approval Of AMLN's Bydureon | June 28, 2010 | BioSpace |
| Ahead of the Bell: Amylin rises following upgrade | June 28, 2010 | Health News - CNBC |
| Weekly Eli Lilly and Company - Amylin Pharmaceuticals, Inc. Diabetes Drug Tops Sanofi-Aventis (France) Drug | June 25, 2010 | BioSpace |
| Amylin Cuts 60 Jobs | June 24, 2010 | Xconomy Life Sciences |
| Amylin Pharmaceuticals, Inc. (AMLN) Lays Off | June 21, 2010 | Biotechnology - Moreover |
| Amylin Pharmaceuticals, Inc. Lays Off 60 Employees for Efficiency | June 21, 2010 | BioSpace |
| Amylin Pharmaceuticals, Inc. to Present New Data and Insights From the Company's Diabetes | June 18, 2010 | BioSpace - Breaking News |
| Amylin Pharmaceuticals to Present New Data and Insights From the Company's Diabetes Programs at ADA 2010 | June 17, 2010 | Clinical Trials - PR Newswire |
| Amylin's Bydureon fails to impress in head-to-head trial | June 16, 2010 | FierceBiotech |
| Amylin shares dip on diabetes drug study results | June 15, 2010 | Health News - CNBC |
| Asterand Signs Agreement with Amylin Pharmaceuticals | June 14, 2010 | Pharma News - Business Wire |
| Amylin Pharmaceuticals to Present at the Goldman Sachs 31st Annual Global Healthcare Conference | June 09, 2010 | Biotech News - PR Newswire |
| Amylin Pharmaceuticals Announces Online Summit | June 07, 2010 | Biotech News - PR Newswire |
| Amylin Pharmaceuticals to Present at the 2010 Jefferies Global Life Sciences Conference | June 02, 2010 | Biotech News - PR Newswire |
| Amylin Pharmaceuticals Appoints Christian Weyer, MD Senior Vice President, Research and Development | June 01, 2010 | Pharma News - PR Newswire |
| Amylin Pharmaceuticals to Present at the 2010 Citi Investment Research Global Healthcare Conference | May 19, 2010 | Biotech News - PR Newswire |
| Amylin faces Oct. 22 FDA review for Bydureon drug | May 06, 2010 | Health News - CNBC |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Alkermes BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 | May 06, 2010 | BioSpace - Breaking News |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company, Alkermes's BYDUREON (TM) FDA Review Timeline Set with PDUFA Action Date of October 22, 2010 | May 06, 2010 | BioSpace |
| Amylin Pharmaceuticals to Present at the Deutsche Bank 35th Annual Healthcare Conference | April 27, 2010 | Biotech News - PR Newswire |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON(TM); to Issue New PDUFA Target Date | April 23, 2010 | BioSpace |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company and Alkermes Submit Reply to FDA Complete Response Letter for BYDUREON(TM) | April 23, 2010 | BioSpace - Breaking News |
| Amylin Pharmaceuticals announces $174.1M total revenue for first-quarter 2010 | April 19, 2010 | Pharmaceutical - Moreover |
| Amylin 1Q loss narrows on lower costs | April 19, 2010 | Health News - CNBC |
| Amylin Pharmaceuticals, Inc. Loss Narrows on Lower Expenses | April 19, 2010 | BioSpace - Breaking News |
| Amylin Pharmaceuticals Narrows Its Quarterly Loss | April 19, 2010 | Health News - Fox Business |
| Amylin Pharmaceuticals Reports First Quarter Financial Results | April 19, 2010 | Biotech News - PR Newswire |
| Walgreen says former Amylin CEO will join board | April 13, 2010 | Health News - CNBC |
| Amylin Pharmaceuticals to Webcast First Quarter Results | April 12, 2010 | Biotech News - PR Newswire |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company's Byetta May Have Cancer Risk, FDA Says | April 12, 2010 | BioSpace |
| Piper Jaffray Initiates Coverage on Amylin Pharmaceutical (AMLN) with a Neutral; Taspoglutide's Safety Could Determine Bydureon's Success | March 29, 2010 | Pharmaceutical - Moreover |
| Sequenom Speaks Out, Amylin Receives a Setback, Somaxon Awaits FDA Decision, & More San Diego Life Sciences News | March 18, 2010 | Xconomy Life Sciences |
| FDA posts observations from Amylin plant visit | March 17, 2010 | FiercePharma Manufacturing |
| Clarification: Amylin FDA info request story | March 16, 2010 | Health News - CNBC |
| Amylin Pharmaceuticals to Present at The Barclays Capital 2010 Global Healthcare Conference | March 16, 2010 | Biotech News - PR Newswire |
| Diabetes Drug From Lilly, Amylin Under Scrutiny | March 15, 2010 | Pharmaceutical - Moreover |
| Movers roundup: Amylin Pharmaceuticals, RadioShack | March 15, 2010 | Health News - CNBC |
| FDA letter moves Amylin drug toward approval | March 15, 2010 | Health News - BizJournals.com |
| Amylin shares up on FDA response for diabetes drug | March 15, 2010 | Health News - CNBC |
| FDA Delays Approval of Amylin Pharmaceuticals, Inc., Eli Lilly and Company Diabetes Drug; Requests Finalization of Product Labeling | March 15, 2010 | BioSpace |
| FDA delays Amylin's Byetta LAR | March 15, 2010 | FierceBiotech |
| FDA Denies Approval of Amylin Pharmaceuticals, Inc., Eli Lilly and Company Diabetes Drug | March 15, 2010 | BioSpace |
| FDA finds shortcomings in Amylin's West Chester plant | March 12, 2010 | Health News - BizJournals.com |
| Amylin shares fall ahead of diabetes drug decision | March 11, 2010 | Health News - CNBC |
| West Wireless Names CEO, Amylin Pharmaceuticals Awaits FDA Deadline, Life Technologies In Cancer Research Partnership, & More San Diego Life Sciences News | March 11, 2010 | Xconomy Life Sciences |
| Amylin Pharmaceuticals, Inc., Eli Lilly and Company Diabetes Drug Faces Crucial FDA Decision | March 10, 2010 | BioSpace |
| Amylin Pharmaceuticals, Inc.'s Exenatide Once Weekly New Drug Application Review Extended By FDA; New PDUFA Action Date March 12 | February 25, 2010 | BioSpace |
| FDA Says "Snow" To Lilly, Amylin & Alkermes | February 25, 2010 | Health News - CNBC |
| Amylin Pharmaceuticals, Inc.'s Exenatide Once Weekly New Drug Application Review Extended By FDA; New PDUFA Action Date March 12 | February 25, 2010 | BioSpace |
| Amylin's Obesity Pipeline Advances | February 25, 2010 | Pharmaceutical - Moreover |
| Amylin and Takeda announce decision to advance development of obesity drug | February 23, 2010 | Pharmaceutical - Moreover |
| Amylin Pharmaceuticals, Inc. and Takeda Pharmaceutical Co. Ltd. Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity Phase 2 Extension Study Demonstrated Sustained Weight Loss | February 23, 2010 | BioSpace - Breaking News |
| Amylin and Takeda Announce Decision to Advance Development of Pramlintide/Metreleptin Combination Treatment for Obesity | February 22, 2010 | Medical Pharma - PR Newswire |
| Study: Ohio overpaid for West Chester Amylin deal | February 01, 2010 | Health News - BizJournals.com |
| Amylin Pharmaceuticals, Inc. Says Key Diabetes Drug to Launch this Year | January 28, 2010 | BioSpace |
| Amylin posts smaller 4Q loss as charges decrease | January 27, 2010 | Health News - CNBC |
| Ahead of the Bell: Amylin Pharmaceuticals | January 26, 2010 | Health News - CNBC |
| Amylin Braces for Big Event of 2010, the (Hoped-For) Approval of Once-Weekly Diabetes Drug | January 22, 2010 | Xconomy Life Sciences |
| U.S. Warns Bayer HealthCare AG , Amylin Pharmaceuticals, Inc. , Cephalon, Inc., Eli Lilly and Company to Stop Using "Misleading" Promotions for Some Drugs | January 13, 2010 | BioSpace - Breaking News |
| U.S. Warns Bayer HealthCare AG, Amylin Pharmaceuticals, Inc., Cephalon, Inc., Eli Lilly and Company to Stop Using "Misleading" Promotions for Some Drugs | January 13, 2010 | BioSpace |
| Amylin Highlights 2010 Corporate Priorities at J.P. Morgan Healthcare Conference | January 12, 2010 | Medical Pharma - PR Newswire |
| Amylin Pharmaceuticals to Present at J.P. Morgan Healthcare Conference | January 04, 2010 | Biotech News - PR Newswire |
| FDA Requests New Studies for Amylin Pharmaceuticals, Inc.'s on Diabetes Drug, Byetta | December 28, 2009 | BioSpace - Breaking News |
| FDA Requests New Studies for Amylin Pharmaceuticals, Inc.'s on Diabetes Drug, Byetta | December 28, 2009 | BioSpace |
| Alkermes, Eli Lilly and Company, And Amylin Pharmaceuticals, Inc. Release:Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study | December 15, 2009 | BioSpace - Breaking News |
